Sleep Deprivation in Palliative Settings Demands a Different Approach

Sleep deprivation in palliative settings is the loss or disruption of sleep among people living with serious, often life-limiting illness. It deserves a different approach from routine insomnia because pain, breathlessness, medication effects, emotional distress, and the goals of care may all shape what “better sleep” means. The National Consensus Project’s palliative-care guidelines emphasize relief of suffering and care aligned with patient preferences; meanwhile, the American Academy of Sleep Medicine recommends cognitive behavioral therapy for insomnia (CBT-I) as a first-line treatment for chronic insomnia in adults generally. In palliative care, that evidence must be adapted: clinicians should first identify and relieve causes of nighttime distress, then choose low-burden behavioral or medication strategies that fit the person’s priorities, prognosis, and care setting.

Palliative Sleep Deprivation: Definition, Burden, and Assessment

Palliative sleep deprivation refers to insufficient, fragmented, or non-restorative sleep in a person receiving care focused on quality of life and relief of serious-illness burden. It is not a diagnosis with one universal threshold: the clinical significance depends on the patient’s experience, daytime effects, underlying illness, and stated goals. The National Cancer Institute describes palliative care as care that prevents or treats symptoms and side effects of serious illness and supports patients and families. Sleep assessment therefore belongs within broader symptom assessment, not apart from it.

Sleep problems are common in serious illness, but prevalence varies substantially by disease, measurement method, and setting. Reviews of cancer-related sleep disturbance report that a sizeable proportion of people with cancer experience insomnia symptoms, with estimates often around 30% to 60%. These figures should not be treated as a single rate for all palliative-care patients: people with advanced cancer, heart or lung disease, dementia, and those approaching end of life have different risks and patterns. A brief sleep history can reveal whether the main issue is trouble falling asleep, repeated waking, early waking, reversed day-night rhythm, or sleep disrupted by care routines.

Insomnia and fragmented sleep

Insomnia is persistent difficulty initiating sleep, maintaining sleep, or returning to sleep after waking, despite adequate opportunity, accompanied by distress or daytime impairment. In palliative settings, repeated waking may reflect pain, coughing, nausea, urinary symptoms, alarms, observations, or worry rather than a primary insomnia disorder. The American Academy of Sleep Medicine’s clinical practice guideline recommends multicomponent CBT-I for chronic insomnia in adults; its components may include stimulus control, sleep scheduling, relaxation, and cognitive strategies. For someone who is frail or nearing end of life, clinicians should adapt or simplify these elements rather than impose a demanding program.

Circadian disruption and daytime sleepiness

Circadian disruption occurs when the body’s internal timing of sleep and wakefulness becomes misaligned with the day-night cycle. Illness, limited daylight exposure, inactivity, hospitalization, dementia, and sedating medicines can contribute. The result may be long daytime naps and wakefulness at night, or sleep distributed in short periods across 24 hours. A simple sleep-and-symptom diary, when practical, can help distinguish a shifted rhythm from sleep lost to pain or care interruptions. Daytime sleepiness also needs careful interpretation: it may signal medication effects, sleep debt, metabolic illness, or progression of disease.

Sleep-disordered breathing and other treatable causes

Sleep-disordered breathing includes conditions such as obstructive sleep apnea, in which breathing repeatedly becomes reduced or stops during sleep. Restless legs symptoms, medication-related movement disorders, delirium, and nocturnal breathlessness can also undermine rest. These conditions may be worth assessing when symptoms are burdensome and a diagnosis would change care. Testing should be proportionate: an investigation that is uncomfortable or unlikely to alter management may not serve a patient whose priority is comfort at home.

Once the sleep pattern and likely contributors are clear, the next step is not automatically a sleeping pill. The central palliative-care question is which causes can be relieved in a way that advances the patient’s own definition of comfort.

Palliative Sleep Deprivation: Causes and Symptom Interactions

Palliative sleep deprivation is usually multifactorial. The European Society for Medical Oncology’s guidance on insomnia in people with cancer describes interacting physical, psychological, behavioral, and treatment-related contributors. A useful assessment examines the whole night: symptoms before bed, medications and their timing, the sleep environment, overnight care, and what happens after a poor night. Addressing a treatable driver may improve sleep without adding another medication.

Pain, breathlessness, and other physical symptoms

Pain may delay sleep or cause repeated awakenings; breathlessness, cough, reflux, itching, nausea, constipation, and urinary frequency can do the same. These symptoms can reinforce one another: fatigue can make coping harder, while anxiety about symptoms can heighten nighttime vigilance. A tailored plan may include reviewing analgesic timing, positioning, airflow or fan use for breathlessness when appropriate, and treatment of other distressing symptoms. Any medication adjustment requires clinical review, particularly when several sedating drugs are already in use.

Emotional distress, uncertainty, and family strain

Fear, depression, grief, and uncertainty can keep attention fixed on symptoms or the future when the person wants to sleep. Family caregivers may also be awake monitoring breathing, responding to alarms, or anticipating crises. The World Health Organization’s palliative-care definition includes support for patients and families facing problems associated with life-threatening illness. Accordingly, listening, clear explanations, psychological or spiritual support, and caregiver guidance can be relevant parts of a sleep plan—not secondary additions.

Medication effects and overnight care routines

Medicines may relieve symptoms yet also cause insomnia, vivid dreams, daytime sedation, or confusion. Corticosteroids, some antidepressants, stimulants, opioids, and other central nervous system medicines can affect sleep differently from person to person. In hospitals and care homes, observations, medication rounds, noise, light, and room sharing can fragment sleep. The Agency for Healthcare Research and Quality’s guidance on improving hospital sleep emphasizes practical attention to environmental disruption and avoidable nighttime interruptions. Teams can review whether non-urgent tasks may be grouped or scheduled differently, while maintaining safe monitoring.

Because causes and priorities differ, treatment should be selected through shared decision-making. That means balancing likely benefit against burden, side effects, and the time and effort a strategy requires.

Palliative Sleep Deprivation: A Goal-Concordant Treatment Approach

A goal-concordant approach treats sleep as a component of comfort and function, not a performance target. Clinicians should ask what the patient hopes to gain: fewer pain-related awakenings, less fear at night, improved alertness for family visits, or simply an easier transition to sleep. The answer may change over time. Plans should be revisited as illness progresses, because a strategy suited to rehabilitation may not suit the last days of life.

Low-burden behavioral and environmental measures

Behavioral measures are non-drug strategies that reduce arousal or make the sleep environment more supportive. Options include a consistent, flexible wind-down routine; daytime light and activity when tolerated; relaxation or breathing exercises; comfortable positioning; reduced nighttime noise and light; and clustering care tasks where safe. Standard CBT-I may be effective for chronic insomnia, but strict sleep restriction or complex homework can be unsuitable for some seriously ill patients. The approach should be simplified, voluntary, and responsive to fatigue and functional capacity.

Medication review and cautious use of hypnotics

Medication review means checking whether existing drugs, doses, timing, or combinations are contributing to poor sleep or excessive sedation. If a sleep medicine is considered, clinicians should weigh the desired effect against risks such as falls, confusion, respiratory suppression, drug interactions, and next-day impairment. The U.S. Food and Drug Administration has warned that combining opioids with benzodiazepines or other central nervous system depressants can cause profound sedation and respiratory depression. That warning is particularly important when a patient has respiratory disease or already uses multiple sedating medicines.

There is no universally preferred sleeping medicine for all palliative-care patients. The choice depends on the cause of insomnia, coexisting conditions, other medicines, likely duration of use, and the patient’s informed preferences. Prescribers should use the lowest effective dose when medication is appropriate, define what benefit is being sought, and reassess whether it is helping.

Care-setting adaptations and real-world application

In a hospital, a practical sleep intervention may involve coordinating vital-sign checks, reducing light and noise, and treating symptoms before bedtime. At home, the plan may focus on a comfortable position, a medication schedule that anticipates predictable symptoms, and caregiver support for nighttime uncertainty. For a person with advanced cancer who wakes repeatedly from pain, for example, the team might reassess pain control and dosing times before adding a hypnotic. For a person with dementia whose sleep-wake cycle has shifted, daytime light, familiar routines, and a safe nighttime environment may be more useful than attempting to enforce a conventional schedule.

These examples illustrate principles rather than substitute for individualized medical advice. The appropriate intervention depends on assessment, clinical judgment, and the patient’s goals.

Palliative Sleep Deprivation: Measuring Benefit and Avoiding Harm

Treatment success should be measured by outcomes that matter to the patient, not only by total hours asleep. A short review can track perceived restfulness, nighttime distress, symptom severity, daytime alertness, falls or confusion, and whether the plan remains acceptable. A sleep diary or brief rating scale can support discussion, but should not become a burden. In palliative care, a modest improvement in comfort may be worthwhile even if sleep remains interrupted; conversely, longer sleep accompanied by distressing confusion may not be a good outcome.

Teams should also recognize when sleep disruption signals a change in illness, delirium, medication toxicity, or uncontrolled symptoms. Sudden changes in alertness, new confusion, severe breathing difficulty, or uncontrolled pain warrant prompt clinical assessment. Family caregivers can be invited to describe patterns they observe, while respecting the patient’s privacy and preferences.

Conclusion: Palliative Sleep Deprivation Requires Individualized Care

Palliative sleep deprivation includes insomnia, fragmented sleep, circadian disruption, and sleep problems caused by illness, treatment, distress, or care environments. Its causes often overlap, so assessment should connect sleep patterns with pain, breathlessness, emotional needs, medication effects, and overnight routines. A different approach is needed because standard insomnia recommendations may require adaptation to prognosis, frailty, and comfort priorities. Begin with the patient’s goals, address reversible burdens, use behavioral and environmental strategies when they are acceptable, and prescribe sedating medicines cautiously. Palliative teams, patients, and caregivers can improve care by raising sleep concerns early and reviewing whether each intervention truly supports comfort and quality of life.

Sources: World Health Organization, Palliative care, https://www.who.int/news-room/fact-sheets/detail/palliative-care; National Cancer Institute, Palliative Care in Cancer, https://www.cancer.gov/about-cancer/advanced-cancer/care-choices/palliative-care-fact-sheet; National Consensus Project for Quality Palliative Care, Clinical Practice Guidelines for Quality Palliative Care, Fourth Edition, https://www.nationalcoalitionhpc.org/ncp-guidelines-2018/; American Academy of Sleep Medicine, Behavioral and Psychological Treatments for Chronic Insomnia Disorder in Adults, https://jcsm.aasm.org/doi/10.5664/jcsm.8986; European Society for Medical Oncology, Insomnia in adult patients with cancer: ESMO Clinical Practice Guideline, https://www.annalsofoncology.org/article/S0923-7534(23)00764-9/fulltext; National Cancer Institute, Sleep Disorders (PDQ), https://www.cancer.gov/about-cancer/treatment/side-effects/sleep-disorders-pdq; Agency for Healthcare Research and Quality, Making Healthcare Safer IV: Improving Sleep in the Hospital, https://effectivehealthcare.ahrq.gov/products/healthcare-safety-practices; U.S. Food and Drug Administration, FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines, https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-serious-risks-and-death-when-combining-opioid-pain-or-cough-medicines

Related Post